echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Nature's latest discovery: a new target for cancer immunotherapy-bacterial peptides

    Nature's latest discovery: a new target for cancer immunotherapy-bacterial peptides

    • Last Update: 2021-05-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Previous studies have shown that a variety of bacteria colonize human tumors, which can affect the tumor microenvironment, such as causing inflammation or local immunosuppression.


    On March 17, researchers from Israel’s Weizmann Institute of Science and other institutions published an article in the journal Nature proving that bacterial protein fragments (bacterial peptides) are presented to the immune system on the surface of tumor cells and are recognized by T cells.


    [1]

    Tumor antigens enable the immune system to distinguish tumor cells from healthy cells.


    Tumor antigens are divided into two categories: tumor-associated antigens and tumor-specific antigens.


    Melanoma has three known tumor-associated antigens.


    The researchers set out to investigate the bacterial composition of 17 melanoma metastases from 9 patients and found that the bacterial composition in different metastases of the same patient was very similar, and similarities were also found in samples from different patients.


    [2]

    Next, they further investigated whether the bacterial peptides in these tumor cells were presented to the immune system in the same way as other intracellular antigens.


    Researchers continue to explore whether bacterial peptides are presented by melanoma cells, rather than by immune cells called antigen presenting cells (APC).


    In summary, the study indicated that bacteria colonizing melanoma can enter melanoma cells, and their peptides can be presented by melanoma HLA-I and HLA-II molecules.


    However, there are still some issues that need attention: First, as true tumor antigens, the identified bacterial species should not invade non-tumor tissues, and their peptides should not be presented by the HLA of non-tumor cells.


    Finally, because the gut and tumor microbiota can affect the survival of cancer patients and their response to treatment, the findings of this study are particularly relevant, suggesting that the mechanisms involved in antigen presentation may be the basis of these effects.


    Reference materials:

    Reference materials:

    [1] Shelly Kalaora et al.


    [1] Shelly Kalaora et al.


    [2] Deborah Nejman et al.


    [3] Bacterial peptides presented on tumour cells could be immunotherapy targets (Source: Nature)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.